From the Stanford Stroke Center (P.S., N.Y., M.M., S.C., G.W.A.), Palo Alto, CA; Neurology Department (P.S., M.O.), Hôpital Fondation A. de Rothschild; Institut de Psychiatrie et Neurosciences de Paris (IPNP) (P.S.), U1266, INSERM, Paris; Acute Stroke Unit (J.M.O., J.-F.A.), Hôpital Pierre-Paul Riquet, CHU Toulouse and CIC 1436, Toulouse University, INSERM, UPS, France; Radiology Department (J.J.H.), Stanford University, Palo Alto, CA; Neurology Department (J.B.E.P., E.C.), Geneva University Hospital, Switzerland; Stroke Center (D.S., P.M., A.S.), Neurology Service, Lausanne University Hospital and University of Lausanne, Switzerland; Neuroradiology Department (M.W., H.C.), MD Anderson Cancer Center, University of Texas, Houston; Neuroradiology Department (C.C.), Toulouse University Hospital; Stroke Unit (I.S., J.S.), Bordeaux University Hospital; and Radiology Department (M.G.L.), Hôpital Fondation A. de Rothschild, Paris, France.
Neurology. 2023 Nov 21;101(21):e2126-e2137. doi: 10.1212/WNL.0000000000207908. Epub 2023 Oct 9.
The optimal methods for predicting early infarct growth rate (EIGR) in acute ischemic stroke with a large vessel occlusion (LVO) have not been established. We aimed to study the factors associated with EIGR, with a focus on the collateral circulation as assessed by the hypoperfusion intensity ratio (HIR) on perfusion imaging, and determine whether the associations found are consistent across imaging modalities.
Retrospective multicenter international study including patients with anterior circulation LVO-related acute stroke with witnessed stroke onset and baseline perfusion imaging (MRI or CT) performed within 24 hours from symptom onset. To avoid selection bias, patients were selected from (1) the prospective registries of 4 comprehensive stroke centers with systematic use of perfusion imaging and including both thrombectomy-treated and untreated patients and (2) 1 prospective thrombectomy study where perfusion imaging was acquired per protocol, but treatment decisions were made blinded to the results. EIGR was defined as infarct volume on baseline imaging divided by onset-to-imaging time and fast progressors as EIGR ≥10 mL/h. The HIR, defined as the proportion of time-to-maximum (Tmax) >6 second with Tmax >10 second volume, was measured on perfusion imaging using RAPID software. The factors independently associated with fast progression were studied using multivariable logistic regression models, with separate analyses for CT- and MRI-assessed patients.
Overall, 1,127 patients were included (CT, n = 471; MRI, n = 656). Median age was 74 years (interquartile range [IQR] 62-83), 52% were male, median NIH Stroke Scale was 16 (IQR 9-21), median HIR was 0.42 (IQR 0.26-0.58), and 415 (37%) were fast progressors. The HIR was the primary factor associated with fast progression, with very similar results across imaging modalities: The proportion of fast progressors was 4% in the first HIR quartile (i.e., excellent collaterals), ∼15% in the second, ∼50% in the third, and ∼77% in the fourth ( < 0.001 for each imaging modality). Fast progression was independently associated with poor 3-month functional outcome in both the CT and MRI cohorts ( < 0.001 and = 0.030, respectively).
The HIR is the primary factor associated with fast infarct progression, regardless of imaging modality. These results have implication for neuroprotection trial design, as well as informing triage decisions at primary stroke centers.
对于大血管闭塞(LVO)急性缺血性卒中患者,预测早期梗死增长率(EIGR)的最佳方法尚未确定。本研究旨在探讨与 EIGR 相关的因素,重点关注灌注成像上的侧支循环灌注不足强度比(HIR)评估,并确定在不同成像方式下发现的相关性是否一致。
本研究为回顾性多中心国际研究,纳入发病时间明确且基线灌注成像(MRI 或 CT)在症状发作后 24 小时内完成的前循环 LVO 相关急性卒中患者。为避免选择偏倚,患者来自 4 家综合卒中中心的前瞻性登记研究,这些中心系统使用灌注成像,包括接受和未接受取栓治疗的患者,以及 1 项前瞻性取栓研究,该研究按照方案采集灌注成像,但治疗决策是在不知道结果的情况下做出的。EIGR 定义为基线成像上的梗死体积除以发病到成像时间,快速进展者定义为 EIGR≥10mL/h。使用 RAPID 软件,在灌注成像上测量 HIR,定义为 Tmax>6 秒且 Tmax>10 秒的时间比例,Tmax>10 秒的体积。使用多变量逻辑回归模型研究与快速进展相关的独立因素,对 CT 和 MRI 评估的患者分别进行分析。
共有 1127 例患者纳入研究(CT 组 471 例,MRI 组 656 例)。中位年龄为 74 岁(四分位距 62-83),52%为男性,中位 NIHSS 评分为 16 分(9-21),中位 HIR 为 0.42(0.26-0.58),415 例(37%)为快速进展者。HIR 是与快速进展最相关的主要因素,在不同的成像方式下得到了非常相似的结果:HIR 四分位 1 (即侧支循环极好)的快速进展比例为 4%,四分位 2 为 15%,四分位 3 为 50%,四分位 4 为 77%(每个成像方式均<0.001)。在 CT 和 MRI 队列中,快速进展均与 3 个月时不良功能结局独立相关(均<0.001 和 = 0.030)。
HIR 是与快速梗死进展最相关的主要因素,与成像方式无关。这些结果对神经保护试验设计具有启示意义,也为初级卒中中心的分诊决策提供了信息。